Measurement of cell kinetic parameters in meningiomas

Neurologia Medico-Chirurgica

Volumn 37, Issue 1, 1997, Pages 12-17

  Nakagawa, Yoshio ^a   Sugawa, Noriaki ^a   Ueda, Satoshi ^a   Suzuki, Kenzo ^b   Vignutelli, Alessandra ^c   Perentes, Elias ^c  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^c Sandoz Pharma Ltd   (Switzerland)

Author keywords

cell cycle; cell kinetics; meningioma; MIB 1

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; CALCULATION; CASE REPORT; CELL CYCLE; CELL KINETICS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR GROWTH; TUMOR VOLUME;

EID: 0031048983     PISSN: 03872572     EISSN: None     Source Type: Journal    
DOI: 10.2176/nmc.37.12     Document Type: Article

References (22)

1. Burger PC, Shibata T, Kleihues P: The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: Application to surgical neuropathology. Am J Surg Pathol 10: 611-617, 1986
2. Cattoretti G, Becker MHG, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357-363, 1992
3. Cho KG, Hoshino T, Nagashima T, Murovic JA, Wilson CB: Prediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labeling. J Neurosurg 65: 790-794, 1986
4. Deckert M, Reifenberger G, Wechsler W: Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67. J Cancer Res Clin Oncol 115: 179-188, 1989
5. Duong DH, Rostomily RC, Haynor DR, Keles GE, Berger MS: Measurement of tumor resection volumes from computerized images. Technical note. J Neurosurg 77: 151-154, 1992
6. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715, 1984
7. Giangaspero F, Doglioni C, Rivano MT, Pileri S, Gerdes J, Stein H: Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol (Berl) 74: 179-182, 1987
8. Hoshino T, Barker M, Wilson CB, Boldrey EB, Fewer D: Cell kinetics of human gliomas. J Neurosurg 37: 15-26, 1972
9. Hoshino T, Ito S, Asai A, Shibuya M, Prados MD, Dodson BA, Davis RL, Wilson CB: Cell kinetic analysis of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine. Int J Cancer 50: 1-5, 1992
10. Hoshino T, Wilson CB: Cell kinetic analyses of human malignant brain tumors (gliomas). Cancer 44: 956-962, 1979
11. Ide M, Jimbo M, Yamamoto M, Umebara Y, Hagiwara S, Kubo O: Growth rate of intracranial meningioma: Tumor doubling time and proliferating cell nuclear antigen staining index. Neurol Med Chir (Tokyo) 35: 289-293, 1995
12. Jääskeläinen J, Haltia M, Laasonen E, Wahlström T, Valtonen S: The growth rate of intracranial meningiomas and its relation to histology. Surg Neurol 24: 165-172, 1985
13. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T: Ki-67 immunoreactivity in human central nervous system tumors: A study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol (Berl) 87: 47-54, 1994
14. Morimura T, Kitz K, Budka H: In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67. Acta Neuropathol (Berl) 77: 276-282, 1989
15. Patsouris E, Stocker U, Kallmeyer V, Keiditsch E, Mehraein P, Stavrou D: Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors. Anticancer Res 8: 537-544, 1988
16. Schröder R, Bien K, Kott R, Meyers I, Vössing R: The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: Demonstration of the variability of the intermitotic cycle time. Acta Neuropathol (Berl) 82: 389-394, 1991
17. Shibuya M, Ito S, Davis RL, Wilson CB, Hoshino T: A new method for analyzing the cell kinetics of human brain tumors by double labeling with bromodeoxyuridine in situ and with iododeoxyuridine in vitro. Cancer 71: 3109-3113, 1993
18. Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20: 22-39, 1957
19. Steel GG: Cell loss from experimental tumors. Cell Tissue Kinet 1: 193-207, 1968
20. Steel GG: Basic theory of growing cell populations, in Steel GG (ed): Growth Kinetics of Tumors. Oxford, Oxford University Press, 1977, pp 56-85
21. Tsanaclis AM, Robert F, Michaud J, Brem S: The cycling pool of cells within human brain tumors: In situ cytokinetics using the monoclonal antibody Ki-67. Can J Neurol Sci 18: 12-17, 1991
22. Zuber P, Hamou MF, de Tribolet N: Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67. Neurosurgery 22: 364-368, 1988